IDH2 and neoplasm: The absence of significant hypermethylation at the examined loci and clustering of this variant with the IDH-negative group, suggests that the variant is unlikely to disrupt normal DNA-methylation-based epigenetic processes in this tumor and is therefore is likely benign.